A lot of the funds raised are going into marketing of the product and protection! (release 25/2) Note the costing for general working capital is quite reasonable imo for the period of time indicated which may suggest the profit when when are well and truly on the way will be quite large! I look forward to seeing if this is in fact the case? If it is, then the 30 million plus earnings by year end 2018 hold it in good stead and obviously allow for some fairly substantial share price appreciation! (Assuming all goes to plan)
- Forums
- ASX - By Stock
- FGL
- Got Wangle?
Got Wangle?, page-5
Featured News
Add FGL (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online